Inside Wall Street: This Tiny Biotech Has Pfizer as a Big Backer
Lpath focuses on developing therapeutics that target bioactive lipids for treating a range of human diseases, including cancer and diseases that cause blindness. Its promising drugs have attracted attention — and lots of money…